Company
Double Blind Bio
The agentic infrastructure for modern clinical trials
- Business model
- B2B
- Customers
- research sites, site networks, biotechnology sponsors, pharmaceutical companies, and contract research organizations
- Legal name
- Double Blind Bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Double Blind Bio streamlines how research sites interface with life science sponsors, leveraging an end-to-end automation platform for clinical trial sites that optimizes administrative workflows.
Funding snapshot
- Total raised
- $5.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.6M2025-12-10
Funding rounds
- Round, 2025
- $5.6M2025-12-10, SEC form D sold, 6 investors
Loading relationship preview